These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14653214)

  • 41. [Fatty hepatosis. Non-alcoholic steatohepatitis (evolution of the knowledge about clinico-morphological features, prognosis, treatment)].
    Podymova SD
    Ter Arkh; 2006; 78(4):32-8. PubMed ID: 16821419
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease.
    Gulsen M; Yesilova Z; Bagci S; Uygun A; Ozcan A; Ercin CN; Erdil A; Sanisoglu SY; Cakir E; Ates Y; Erbil MK; Karaeren N; Dagalp K
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1448-55. PubMed ID: 16105135
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Nonalcoholic steatohepatitis--current treatment options].
    Gutkowski K; Gutkowska D; Partyka M
    Przegl Lek; 2006; 63(2):91-4. PubMed ID: 16967716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nutritional indices in cirrhotic patients.
    Piquet MA; Ollivier I; Gloro R; Castel H; Tiengou LE; Dao T
    Nutrition; 2006 Feb; 22(2):216-7; author reply 218-9. PubMed ID: 16459237
    [No Abstract]   [Full Text] [Related]  

  • 46. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.
    Wieckowska A; Zein NN; Yerian LM; Lopez AR; McCullough AJ; Feldstein AE
    Hepatology; 2006 Jul; 44(1):27-33. PubMed ID: 16799979
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New concepts in the pathogenesis of alcoholic liver disease.
    Albano E
    Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):749-59. PubMed ID: 19090736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Acute alcoholic hepatitis].
    Vŭrbanov G
    Vutr Boles; 1985; 24(6):10-6. PubMed ID: 3913141
    [No Abstract]   [Full Text] [Related]  

  • 50. Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis.
    Abiru S; Migita K; Maeda Y; Daikoku M; Ito M; Ohata K; Nagaoka S; Matsumoto T; Takii Y; Kusumoto K; Nakamura M; Komori A; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
    Liver Int; 2006 Feb; 26(1):39-45. PubMed ID: 16420507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
    Helling TS; Helzberg JH; Nachnani JS; Gurram K
    Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical and morphological features of alcoholic steatohepatitis].
    Mansurov KhKh; Mirodzhov GK; Mansurova FKh; Odinaev RI; Khuzhamuratov MKh
    Klin Med (Mosk); 2005; 83(4):37-40. PubMed ID: 15941141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of genes encoding mitochondrial proteins can distinguish nonalcoholic steatosis from steatohepatitis.
    Bragoszewski P; Habior A; Walewska-Zielecka B; Ostrowski J
    Acta Biochim Pol; 2007; 54(2):341-8. PubMed ID: 17502923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonalcoholic fatty liver disease: is all the fat bad?
    Clouston AD; Powell EE
    Intern Med J; 2004 Apr; 34(4):187-91. PubMed ID: 15086699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Regression of fatty liver].
    Thaler H
    Dtsch Med Wochenschr; 1989 Aug; 114(31-32):1224. PubMed ID: 2666084
    [No Abstract]   [Full Text] [Related]  

  • 56. [Nonalcoholic steatohepatitis: a clinicopathological analysis of liver biopsy in 32 cases].
    Meng JR; Zheng RD; Zhang MF; Guo YH; Lin MZ; Dai TJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):339-41. PubMed ID: 16546742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Controversies in the determination of serum albumin concentration in chronic liver diseases].
    Uchida Y; Okuzumi Y; Fujishiro M; Kawamura K; Shibasaki M; Shimetani N; Suzuki K
    Rinsho Byori; 2006 Oct; 54(10):1008-12. PubMed ID: 17133989
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathologic assessment of non-alcoholic fatty liver disease.
    Bondini S; Kleiner DE; Goodman ZD; Gramlich T; Younossi ZM
    Clin Liver Dis; 2007 Feb; 11(1):17-23, vii. PubMed ID: 17544969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnosis and therapy of nonalcoholic steatohepatitis.
    Torres DM; Harrison SA
    Gastroenterology; 2008 May; 134(6):1682-98. PubMed ID: 18471547
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Icterus in pregnancy].
    Eisenburg J
    Munch Med Wochenschr; 1971 Nov; 113(48):1609-18. PubMed ID: 5171927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.